The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Carbapenemase-Producing Organisms: A Global Scourge
Open accessAbstract
The dramatic increase in the prevalence and clinical impact of infections caused by bacteria producing carbapenemases is a global health concern. Carbapenemase production is especially problematic when encountered in members of the family Enterobacteriaceae. Due to their ability to readily spread and colonize patients in healthcare environments, preventing the transmission of these organisms is a major public health initiative and coordinated international effort are needed. Central to the treatment and control of carbapenemase-producing organisms (CPOs) are phenotypic (growth-/biochemical-dependent) and nucleic acid-based carbapenemase detection tests that identify carbapenemase activity directly or their associated molecular determinants. Importantly, bacterial isolates harboring carbapenemases are often resistant to multiple antibiotic classes, resulting in limited therapy options. Emerging agents, novel antibiotic combinations and treatment regimens offer promise for management of these infections. This review highlights our current understanding of CPOs with emphasis on their epidemiology, detection, treatment, and control.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Performance standards for antimicrobial susceptibility testing
Ferraro, M. J. (2001) · Cited by 9,667
Liu, Y.-Y., Wang, Y., Walsh, T. R., Yi, L.-X., Zhang, R., Spencer, J., Doi, Y., Tian, G., Dong, B., Huang, X., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00424-7 · Cited by 5,398
Performance standards for antimicrobial susceptibility testing
Weinstein, M. P., & Clinical (2019) · Clinical and Laboratory Standards Institute eBooks · Cited by 4,341
Carbapenemases: the Versatile β-Lactamases
Queenan, A. M., & Bush, K. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00001-07 · Cited by 2,499
Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases
Munoz-Price, L. S., Poirel, L., Bonomo, R. A., Schwaber, M. J., Daikos, G. L., Cormican, M., Cornaglia, G., Garau, J., Gniadkowski, M., Hayden, M. K., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70190-7 · Cited by 1,627
Self-citationMetallo-β-Lactamases: the Quiet before the Storm?
Walsh, T. R., Toleman, M. A., Poirel, L., & Nordmann, P. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.2.306-325.2005 · Cited by 1,431
Self-citationWalsh, T. R., Weeks, J., Livermore, D. M., & Toleman, M. A. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70059-7 · Cited by 1,250
Tumbarello, M., Viale, P., Viscoli, C., Trecarichi, E. M., Tumietto, F., Marchese, A., Spanu, T., Ambretti, S., Ginocchio, F., Cristini, F., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis588 · Cited by 1,016
OXA-48-like carbapenemases: the phantom menace
Poirel, L., Potron, A., & Nordmann, P. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks121 · Cited by 924
Self-citationSnitkin, E. S., Zelazny, A. M., Thomas, P. J., Stock, F., Program, N. C. S., Henderson, D. K., Palmore, T. N., & Segre, J. A. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004129 · Cited by 863
Self-citationRapid Detection of Carbapenemase-producing Enterobacteriaceae
Nordmann, P., Poirel, L., & Dortet, L. (2012) · Emerging Infectious Diseases · doi:10.3201/eid1809.120355 · Cited by 761
Self-citationPotron, A., Poirel, L., & Nordmann, P. (2015) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.03.001 · Cited by 688
Self-citationThe difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide
Nordmann, P., & Poirel, L. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12719 · Cited by 679
Self-citationvan Duin, D., Lok, J. J., Earley, M., Cober, E., Richter, S. S., Perez, F., Salata, R. A., Kalayjian, R. C., Watkins, R. R., Doi, Y., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/cix783 · Cited by 655
Self-citationRapid Whole-Genome Sequencing for Investigation of a Neonatal MRSA Outbreak
Köser, C. U., Holden, M. T. G., Ellington, M. J., Cartwright, E. J. P., Brown, N. M., Ogilvy-Stuart, A. L., Hsu, L. Y., Chewapreecha, C., Croucher, N. J., Harris, S. R., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1109910 · Cited by 654
Harris, S. R., Cartwright, E. J., Török, M. E., Holden, M. T., Brown, N. M., Ogilvy-Stuart, A. L., Ellington, M. J., Quail, M. A., Bentley, S. D., Parkhill, J., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(12)70268-2 · Cited by 564
Qureshi, Z. A., Paterson, D. L., Potoski, B. A., Kilayko, M. C., Sandovsky, G., Sordillo, E., Polsky, B., Adams-Haduch, J. M., & Doi, Y. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06268-11 · Cited by 559
Routine Use of Microbial Whole Genome Sequencing in Diagnostic and Public Health Microbiology
Köser, C. U., Ellington, M. J., Cartwright, E. J. P., Gillespie, S. H., Brown, N. M., Farrington, M., Holden, M. T. G., Dougan, G., Bentley, S. D., Parkhill, J., et al. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002824 · Cited by 544
International Health Regulations (2005)
Merianos, A., & Peiris, M. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67508-3 · Cited by 523
Metallo‐β‐lactamase structure and function
Palzkill, T. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06796.x · Cited by 505
van der Zwaluw, K., de Haan, A., Pluister, G. N., Bootsma, H. J., de Neeling, A. J., & Schouls, L. M. (2015) · PLOS ONE · doi:10.1371/journal.pone.0123690 · Cited by 486
Schwaber, M. J., Lev, B., Israeli, A., Solter, E., Smollan, G., Rubinovitch, B., Shalit, I., Carmeli, Y., & the Israel Carbapenem-Resistant Enterobacteriaceae Working Group (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir025 · Cited by 453
Shields, R. K., Potoski, B. A., Haidar, G., Hao, B., Doi, Y., Chen, L., Press, E. G., Kreiswirth, B. N., Clancy, C. J., & Nguyen, M. H. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw636 · Cited by 430
Pierce, V. M., Simner, P. J., Lonsway, D. R., Roe-Carpenter, D. E., Johnson, J. K., Brasso, W. B., Bobenchik, A. M., Lockett, Z. C., Charnot-Katsikas, A., Ferraro, M. J., et al. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.00193-17 · Cited by 405
Self-citationPotent CD8+ T-Cell Immunogenicity in Humans of a Novel Heterosubtypic Influenza A Vaccine, MVA-NP+M1
Berthoud, T. K., Hamill, M., Lillie, P. J., Hwenda, L., Collins, K. A., Ewer, K. J., Milicic, A., Poyntz, H. C., Lambe, T., Fletcher, H. A., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq015 · Cited by 384
Falagas, M. E., Lourida, P., Poulikakos, P., Rafailidis, P. I., & Tansarli, G. S. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01222-13 · Cited by 351
Treating infections caused by carbapenemase-producing Enterobacteriaceae
Tzouvelekis, L. S., Markogiannakis, A., Piperaki, E., Souli, M., & Daikos, G. L. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12697 · Cited by 337
Conlan, S., Thomas, P. J., Deming, C., Park, M., Lau, A. F., Dekker, J. P., Snitkin, E. S., Clark, T. A., Luong, K., Song, Y., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009845 · Cited by 333
Self-citationSalimnia, H., Fairfax, M. R., Lephart, P. R., Schreckenberger, P., DesJarlais, S. M., Johnson, J. K., Robinson, G., Carroll, K. C., Greer, A., Morgan, M., et al. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.01679-15 · Cited by 243
Tsakris, A., Poulou, A., Pournaras, S., Voulgari, E., Vrioni, G., Themeli-Digalaki, K., Petropoulou, D., & Sofianou, D. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq210 · Cited by 242
Carpentier, A., Metellus, P., Ursu, R., Zohar, S., Lafitte, F., Barrie, M., Meng, Y., Richard, M., Parizot, C., Laigle-Donadey, F., et al. (2010) · Neuro-Oncology · doi:10.1093/neuonc/nop047 · Cited by 206
International Health Regulations
(2008) · Encyclopedia of Public Health · doi:10.1007/978-1-4020-5614-7_1854 · Cited by 188
Edelstein, M. V., Skleenova, E. N., Shevchenko, O. V., D'souza, J. W., Tapalski, D. V., Azizov, I. S., Sukhorukova, M. V., Pavlukov, R. A., Kozlov, R. S., Toleman, M. A., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70168-3 · Cited by 178
New β-Lactamase Inhibitors in the Clinic
Papp-Wallace, K. M., & Bonomo, R. A. (2016) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2016.02.007 · Cited by 162
Self-citationPérez, F., Chakhtoura, N. G. E., Papp‐Wallace, K. M., Wilson, B. M., & Bonomo, R. A. (2016) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2016.1145658 · Cited by 157
Self-citationTato, M., Ruíz-Garbajosa, P., Traczewski, M. M., Dodgson, A. R., McEwan, A. K., Humphries, R. M., Hindler, J. A., Veltman, J., Wang, H., & Cantón, R. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.00341-16 · Cited by 150
Mathers, A. J., Stoesser, N. E., Sheppard, A. E., Pankhurst, L. J., Giess, A. P., Yeh, A. J., Didelot, X., Turner, S., Sebra, R., Kasarskis, A., et al. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04292-14 · Cited by 148
Potron, A., Poirel, L., & Nordmann, P. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01344-13 · Cited by 134
Self-citationOptimizing antimicrobial pharmacodynamics: dosage strategies for meropenem
Mattoes, H. M., Kuti, J. L., Drusano, G. L., & Nicolau, D. P. (2004) · Clinical Therapeutics · doi:10.1016/s0149-2918(04)80001-8 · Cited by 118
Pecora, N., Li, N., Allard, M. W., Li, C., Albano, E., Delaney, M. L., DuBois, A. M., Onderdonk, A. B., & Bry, L. (2015) · mBio · doi:10.1128/mbio.01030-15 · Cited by 99
Detection of Carbapenemases in Enterobacteriaceae by a Commercial Multiplex PCR
Kaase, M., Szabados, F., Wassill, L., & Gatermann, S. G. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.00991-12 · Cited by 97
Wernli, D., Haustein, T., Conly, J. M., Carmeli, Y., Kickbusch, I., & Harbarth, S. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1001022 · Cited by 90
Self-citationDodémont, M., Mendonça, R. D., Nonhoff, C., Roisin, S., & Denis, O. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.01099-14 · Cited by 88
Complete sequence of two KPC-harbouring plasmids from Pseudomonas aeruginosa
Naas, T., Bonnin, R. A., Cuzon, G., Villegas, M. V., & Nordmann, P. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt094 · Cited by 70
Poirel, L., Kieffer, N., & Nordmann, P. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv294 · Cited by 70
Self-citationTranscriptome Remodeling of Acinetobacter baumannii during Infection and Treatment
Wright, M. S., Jacobs, M. R., Bonomo, R. A., & Adams, M. D. (2017) · mBio · doi:10.1128/mbio.02193-16 · Cited by 38
Self-citation
Cited by
Past and Present Perspectives on β-Lactamases
Bush, K. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01076-18 · Cited by 832
Epidemiology and Diagnostics of Carbapenem Resistance in Gram-negative Bacteria
Nordmann, P., & Poirel, L. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz824 · Cited by 721
Self-citationIdentification of antimicrobial peptides from the human gut microbiome using deep learning
Ma, Y., Guo, Z., Xia, B., Zhang, Y., Liu, X., Yu, Y., Tang, N., Tong, X., Wang, M., Ye, X., et al. (2022) · Nature Biotechnology · doi:10.1038/s41587-022-01226-0 · Cited by 490
Hammoudi Halat, D., & Ayoub Moubareck, C. (2020) · Antibiotics · doi:10.3390/antibiotics9040186 · Cited by 287
Rationalizing antimicrobial therapy in the ICU: a narrative review
Timsit, J.-F., Bassetti, M., Cremer, O., Daikos, G., de Waele, J., Kallil, A., Kipnis, E., Kollef, M., Laupland, K., Paiva, J.-A., et al. (2019) · Intensive Care Medicine · doi:10.1007/s00134-019-05520-5 · Cited by 266
Metadata
- Authors
- Bonomo, R. A., Burd, E. M., Conly, J., Limbago, B. M., Poirel, L., Segre, J. A., & Westblade, L. F.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-10-16
- Volume
- 66
- Issue
- 8
- Pages
- 1290-1297
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2769199871
- Cited by
- 656
- References
- 46
- FWCI
- 13.87
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.